Literature DB >> 15581048

Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distress.

Shirley S Hwang1, Charles B Scott, Victor T Chang, Janet Cogswell, Shanthi Srinivas, Basil Kasimis.   

Abstract

We performed an exploratory recursive partitioning analysis (RPA) in 429 metastatic cancer patients who had completed a Functional Assessment of Cancer Therapy-General (FACT-G) and a Memorial Symptom Assessment Scale-Short Form (MSAS-SF) to define survival prognostic groups. The Cox model analysis also was performed. Both RPA and Cox models included Karnofsky performance status (KPS), age, FACT-G subscales, and MSAS-SF subscales as survival predictors. Of 429 patients, 348 patients (81.1%) had expired at time of analysis. The median age was 67 years (27-89), with median length of survival of 147 days. The RPA identified four distinct survival groups (p < .0001) with three variables: KPS, physical well-being, and physical symptom distress. The most significant split was KPS of 50%, followed by physical well-being score of 25 and physical symptom distress score of 0.6. The median survival time was 29 days for patients with KPS < 50%; 146 days for patients with KPS > or = 50% and physical well-being < 25; 292 days for patients with KPS > 50%, physical well-being > or = 25, and physical symptom distress score > 0.6; and 610 days for patients with KPS > or = 50%, physical well-being > or = 25, and physical symptom distress score < or = 0.6. The Cox model found, in addition to KPS (p < .0001) and physical well-being (p = .08), different predictors: psychological symptom distress (p = .0007), global distress index (p = .02), and age (p < .0001). We concluded that the KPS, quality of life, and symptom distress scores can be combined to define prognostic groups. Such models may be helpful for clinical decision making.

Entities:  

Mesh:

Year:  2004        PMID: 15581048     DOI: 10.1081/cnv-200032911

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  27 in total

1.  Can Positive Resection Margin of Intra-hepatic Cholangiocarcinoma Still Provide a Survival Benefit over Systemic Chemotherapy?

Authors:  Alessandro Cucchetti; Valentina Bertuzzo; Antonio Daniele Pinna
Journal:  World J Surg       Date:  2015-12       Impact factor: 3.352

2.  Effect of Baduanjin Qigong Exercise on Cancer-Related Fatigue in Patients with Colorectal Cancer Undergoing Chemotherapy: A Randomized Controlled Trial.

Authors:  Yun Lu; Hui-Qin Qu; Feng-Ying Chen; Xiao-Ting Li; Lan Cai; Shan Chen; Yuan-Yuan Sun
Journal:  Oncol Res Treat       Date:  2019-07-02       Impact factor: 2.825

Review 3.  A framework for assessment in oncology rehabilitation.

Authors:  Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness
Journal:  Phys Ther       Date:  2009-01-15

4.  Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer: a randomized trial.

Authors:  Jean S Kutner; Marlaine C Smith; Lisa Corbin; Linnea Hemphill; Kathryn Benton; B Karen Mellis; Brenda Beaty; Sue Felton; Traci E Yamashita; Lucinda L Bryant; Diane L Fairclough
Journal:  Ann Intern Med       Date:  2008-09-16       Impact factor: 25.391

5.  Predicting compliance and survival in palliative whole-brain radiotherapy for brain metastases.

Authors:  Sebastià Sabater; Encarna Mur; Katrin Müller; Meritxell Arenas
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

6.  Expression profile of ACTL8, CTCFL, OIP5 and XAGE3 in glioma and their prognostic significance: a retrospective clinical study.

Authors:  Xisheng Li; Lidong Ning; Qingmei Zhang; Yingying Ge; Chang Liu; Shuiqing Bi; Xia Zeng; Weixia Nong; Song Wu; Gaoshui Guo; Shaowen Xiao; Bin Luo; Xiaoxun Xie
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

7.  Biological, clinical, and psychosocial correlates at the interface of cancer and aging research.

Authors:  William Dale; Supriya G Mohile; Basil A Eldadah; Edward L Trimble; Richard L Schilsky; Harvey J Cohen; Hyman B Muss; Kenneth E Schmader; Betty Ferrell; Martine Extermann; Susan G Nayfield; Arti Hurria
Journal:  J Natl Cancer Inst       Date:  2012-03-27       Impact factor: 13.506

8.  Predicting fatigue in older breast cancer patients receiving radiotherapy. A head-to-head comparison of established assessments.

Authors:  Michael Dieter Denkinger; Melanie Hasch; Anna Gerstmayer; Rolf Kreienberg; Thorsten Nikolaus; Katharina Hancke
Journal:  Z Gerontol Geriatr       Date:  2015-01-16       Impact factor: 1.281

9.  Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer.

Authors:  Wang Zhongmin; Liu Yu; Liu Fenju; Chen Kemin; Huang Gang
Journal:  Eur Radiol       Date:  2010-01-13       Impact factor: 5.315

10.  The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'.

Authors:  Julian Lindsay; Michael Dooley; Jennifer Martin; Michael Fay; Alison Kearney; Mohsina Khatun; Michael Barras
Journal:  Support Care Cancer       Date:  2014-07-01       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.